Deferred Tax Assets, Valuation Allowance of Dare Bioscience, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Dare Bioscience, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Dare Bioscience, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $114,668,000, a 2.1% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Dare Bioscience, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $114,668,000 +$2,389,000 +2.1% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $112,279,000 +$8,038,000 +7.7% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $104,241,000 +$4,480,000 +4.5% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $99,761,000 +$14,464,000 +17% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $85,297,000 +$22,127,000 +35% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $63,170,000 +$4,127,000 +7% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q4 2018 $59,043,000 +$3,099,000 +5.5% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q4 2017 $55,944,000 +$55,654,000 +19191% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q2 2017 $220,500 30 Jun 2017 8-K/A 02 Oct 2017
Q4 2016 $290,000 -$60,168,000 -100% 31 Dec 2016 10-K 28 Mar 2018 2017 FY
Q4 2015 $60,458,000 +$60,412,980 31 Dec 2015 10-K/A 13 Jun 2017 2016 FY
Q4 2014 $45,020* +$7,520 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q4 2013 $37,500* 31 Dec 2013 10-K 19 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.